Patient Compliance

David Snow, founder, chairman and CEO of Cedar Gate Technologies, discusses how value-based care has changed over the years and its current challenges.

Yuflyma is a treatment for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and more.

The acquisition of Cimerli, a biosimilar of Lucentis, strengthens Sandoz's ophthalmology portfolio.

Labor challenges, the expansion of healthcare services, store-count rationalization and PBM reform are among the front-burner issues in the year ahead.

The Future of Pharmacy Care Coalition is urging the 118th Congress to Enact H.R. 1770 to protect Medicare beneficiaries from the harms of COVID-19, flu, RSV and other infectious diseases.

Febuxostat tablets are indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol.

Lupin has received the FDA's nod for generic Inderal LA ER Capsules, and the company has introduced generic Chantix and generic Prolensa.

Aetna’s $75,000 donation to the Plano Childhood Development Center is aimed at helping children receive the eyecare and intervention they need.